News
17 October, 2024
Position of the Transparency Council – Citrulline 200, Citrulline 1000, L-Citrulline
more...17 October, 2024
Position of the Transparency Council – Determination of estriol as part of non-invasive prenatal diagnosis
more...17 October, 2024
Position of the Transparency Council – Determination of alpha-fetoprotein as part of non-invasive prenatal diagnosis
more...17 October, 2024
Position of the Transparency Council – Placental Growth Factor (PlGF) determination
more...17 October, 2024
Communication of the meeting of Transparency Council No. 43/2024 on 14 October 2024
more...14 October, 2024
Opinion of the President – health policy program for early detection of overweight, obesity and type 2 diabetes among economically active adult residents of the Municipality of the City of Torun titled Qźnia zdrowia
more...14 October, 2024
Opinion of the President – health policy program in support of diagnosis and treatment of infertility in the Lower Silesian Province
more...14 October, 2024
Opinion of the President – preventive vaccination program against meningococcus in the Municipality of Masłów for 2025-2029
more...10 October, 2024
Meeting of the National Competent Authorities on Pricing and Reimbursement and Public Healthcare Payers (NCAPR)
more...09 October, 2024
Communication of the meeting of Transparency Council No. 42/2024 on 7 October
more...04 October, 2024
Opinion of the President – health prevention program in the field of medical rehabilitation of the residents of the Mściwojów Municipality in 2024
more...04 October, 2024
Opinion of the President – Health policy program for the prevention and early detection of overweight and obesity among students in grades I-III of elementary schools from the Warmian-Masurian voivodeship
more...04 October, 2024
Opinion of the President – program for the prevention of depressive disorders among adolescents attending schools in the Municipality of the City of Marki for 2025- 2027
more...04 October, 2024
Recommendation of the President – Imjudo (tremelimumab) + Imfinzi (durvalumab)
more...04 October, 2024
Recommendation of the President – Imfinzi (durvalumab) + Imjudo (tremelimumab)
more...04 October, 2024